Illumina Net Worth
Illumina Net Worth Breakdown | ILMN |
Illumina Net Worth Analysis
Illumina's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Illumina's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Illumina's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Illumina's net worth analysis. One common approach is to calculate Illumina's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Illumina's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Illumina's net worth. This approach calculates the present value of Illumina's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Illumina's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Illumina's net worth. This involves comparing Illumina's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Illumina's net worth relative to its peers.
Enterprise Value |
|
To determine if Illumina is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Illumina's net worth research are outlined below:
| Illumina generated a negative expected return over the last 90 days | |
| Illumina currently holds 2.54 B in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. Illumina has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Illumina's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 4.37 B. Net Loss for the year was (1.22 B) with profit before overhead, payroll, taxes, and interest of 2.99 B. | |
| Over 100.0% of Illumina shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to Determine Clonal Tumor Mutation Burden |
Illumina Quarterly Good Will |
|
Illumina uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Illumina. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Illumina's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 23rd of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Illumina Target Price Consensus
Illumina target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Illumina's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 25 | Buy |
Most Illumina analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Illumina stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Illumina, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationIllumina Target Price Projection
Illumina's current and average target prices are 85.60 and 162.52, respectively. The current price of Illumina is the price at which Illumina is currently trading. On the other hand, Illumina's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Illumina Target Price
Know Illumina's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Illumina is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Illumina backward and forwards among themselves. Illumina's institutional investor refers to the entity that pools money to purchase Illumina's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Hhg Plc | 2024-12-31 | 2.2 M | Brown Advisory Holdings Inc | 2024-12-31 | 1.9 M | Norges Bank | 2024-12-31 | 1.7 M | Corvex Management Lp | 2024-12-31 | 1.7 M | Alliancebernstein L.p. | 2024-12-31 | 1.7 M | Northern Trust Corp | 2024-12-31 | 1.7 M | Bank Of America Corp | 2024-12-31 | 1.6 M | Pointstate Capital Lp | 2024-12-31 | 1.6 M | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 1.5 M | Blackrock Inc | 2024-12-31 | 19.3 M | Capital World Investors | 2024-12-31 | 18 M |
Follow Illumina's market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 13.56 B.Market Cap |
|
Project Illumina's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.23) | (0.22) | |
| Return On Capital Employed | (0.13) | (0.11) | |
| Return On Assets | (0.10) | (0.10) | |
| Return On Equity | (0.18) | (0.17) |
When accessing Illumina's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Illumina's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Illumina's profitability and make more informed investment decisions.
Evaluate Illumina's management efficiency
Illumina has return on total asset (ROA) of 0.0264 % which means that it generated a profit of $0.0264 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3013) %, meaning that it created substantial loss on money invested by shareholders. Illumina's management efficiency ratios could be used to measure how well Illumina manages its routine affairs as well as how well it operates its assets and liabilities. As of the 17th of March 2025, Return On Tangible Assets is likely to grow to -0.22. In addition to that, Return On Capital Employed is likely to grow to -0.11. At this time, Illumina's Non Currrent Assets Other are very stable compared to the past year. As of the 17th of March 2025, Other Current Assets is likely to grow to about 256.2 M, while Total Assets are likely to drop about 4.1 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 32.72 | 34.36 | |
| Tangible Book Value Per Share | 1.18 | 1.12 | |
| Enterprise Value Over EBITDA | (33.45) | (31.77) | |
| Price Book Value Ratio | 3.35 | 5.39 | |
| Enterprise Value Multiple | (33.45) | (31.77) | |
| Price Fair Value | 3.35 | 5.39 | |
| Enterprise Value | 1.5 B | 1.6 B |
Illumina has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Enterprise Value Revenue 3.422 | Revenue | Quarterly Revenue Growth (0.02) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Illumina insiders, such as employees or executives, is commonly permitted as long as it does not rely on Illumina's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Illumina insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ankur Dhingra over two weeks ago Acquisition by Ankur Dhingra of 9803 shares of Illumina subject to Rule 16b-3 | ||
Pat Leckman over two months ago Disposition of 1068 shares by Pat Leckman of Illumina at 138.65 subject to Rule 16b-3 | ||
Jacob Thaysen over three months ago Disposition of 914 shares by Jacob Thaysen of Illumina at 140.66 subject to Rule 16b-3 | ||
Jacob Thaysen over three months ago Acquisition by Jacob Thaysen of 7426 shares of Illumina subject to Rule 16b-3 | ||
Ullem Scott B. over six months ago Acquisition by Ullem Scott B. of 163 shares of Illumina at 137.682 subject to Rule 16b-3 | ||
Roy Whitfield over a year ago Exercise or conversion by Roy Whitfield of 800 shares of Illumina subject to Rule 16b-3 |
Illumina Corporate Filings
8K | 10th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 7th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 12th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
13A | 6th of December 2024 An amended filing to the original Schedule 13G | ViewVerify |
Illumina Earnings Estimation Breakdown
The calculation of Illumina's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Illumina is estimated to be 0.9404 with the future projection ranging from a low of 0.81 to a high of 0.974. Please be aware that this consensus of annual earnings estimates for Illumina is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.81 Lowest | Expected EPS | 0.97 Highest |
Illumina Earnings Projection Consensus
Suppose the current estimates of Illumina's value are higher than the current market price of the Illumina stock. In this case, investors may conclude that Illumina is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Illumina's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 25 | 45.85% | 0.86 | 0.9404 | -7.69 |
Illumina Earnings History
Earnings estimate consensus by Illumina analysts from Wall Street is used by the market to judge Illumina's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Illumina's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Illumina Quarterly Gross Profit |
|
Illumina Earnings per Share Projection vs Actual
Actual Earning per Share of Illumina refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Illumina predict the company's earnings will be in the future. The higher the earnings per share of Illumina, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Illumina Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Illumina, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Illumina should always be considered in relation to other companies to make a more educated investment decision.Illumina Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Illumina's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-06 | 2024-12-31 | 0.9228 | 0.86 | -0.0628 | 6 | ||
2024-11-07 | 2024-09-30 | 0.88 | 1.14 | 0.26 | 29 | ||
2024-08-06 | 2024-06-30 | 0.9 | 0.36 | -0.54 | 60 | ||
2024-05-02 | 2024-03-31 | 0.04 | 0.09 | 0.05 | 125 | ||
2024-02-08 | 2023-12-31 | 0.02 | 0.14 | 0.12 | 600 | ||
2023-11-09 | 2023-09-30 | 0.12 | 0.33 | 0.21 | 175 | ||
2023-08-09 | 2023-06-30 | 0.02 | 0.32 | 0.3 | 1500 | ||
2023-04-25 | 2023-03-31 | 0.03 | 0.08 | 0.05 | 166 | ||
2023-02-07 | 2022-12-31 | 0.1 | 0.14 | 0.04 | 40 | ||
2022-11-03 | 2022-09-30 | 0.3 | 0.34 | 0.04 | 13 | ||
2022-08-11 | 2022-06-30 | 0.65 | 0.57 | -0.08 | 12 | ||
2022-05-05 | 2022-03-31 | 0.9 | 1.07 | 0.17 | 18 | ||
2022-02-10 | 2021-12-31 | 0.49 | 0.75 | 0.26 | 53 | ||
2021-11-04 | 2021-09-30 | 1.14 | 1.45 | 0.31 | 27 | ||
2021-08-05 | 2021-06-30 | 1.36 | 1.87 | 0.51 | 37 | ||
2021-04-27 | 2021-03-31 | 1.38 | 1.89 | 0.51 | 36 | ||
2021-02-11 | 2020-12-31 | 1.11 | 1.22 | 0.11 | 9 | ||
2020-10-29 | 2020-09-30 | 0.77 | 1.02 | 0.25 | 32 | ||
2020-08-06 | 2020-06-30 | 0.67 | 0.62 | -0.05 | 7 | ||
2020-04-30 | 2020-03-31 | 1.25 | 1.64 | 0.39 | 31 | ||
2020-01-29 | 2019-12-31 | 1.58 | 1.7 | 0.12 | 7 | ||
2019-10-24 | 2019-09-30 | 1.4 | 1.93 | 0.53 | 37 | ||
2019-07-29 | 2019-06-30 | 1.34 | 1.35 | 0.01 | 0 | ||
2019-04-25 | 2019-03-31 | 1.34 | 1.6 | 0.26 | 19 | ||
2019-01-29 | 2018-12-31 | 1.36 | 1.32 | -0.04 | 2 | ||
2018-10-23 | 2018-09-30 | 1.26 | 1.52 | 0.26 | 20 | ||
2018-07-30 | 2018-06-30 | 1.11 | 1.43 | 0.32 | 28 | ||
2018-04-24 | 2018-03-31 | 1.02 | 1.45 | 0.43 | 42 | ||
2018-01-30 | 2017-12-31 | 1.22 | 1.44 | 0.22 | 18 | ||
2017-10-24 | 2017-09-30 | 0.99 | 1.11 | 0.12 | 12 | ||
2017-08-01 | 2017-06-30 | 0.69 | 0.82 | 0.13 | 18 | ||
2017-04-25 | 2017-03-31 | 0.64 | 0.64 | 0.0 | 0 | ||
2017-01-31 | 2016-12-31 | 0.82 | 0.85 | 0.03 | 3 | ||
2016-11-01 | 2016-09-30 | 0.87 | 0.97 | 0.1 | 11 | ||
2016-07-26 | 2016-06-30 | 0.73 | 0.86 | 0.13 | 17 | ||
2016-05-03 | 2016-03-31 | 0.74 | 0.71 | -0.03 | 4 | ||
2016-02-02 | 2015-12-31 | 0.82 | 0.81 | -0.01 | 1 | ||
2015-10-20 | 2015-09-30 | 0.79 | 0.8 | 0.01 | 1 | ||
2015-07-21 | 2015-06-30 | 0.77 | 0.8 | 0.03 | 3 | ||
2015-04-21 | 2015-03-31 | 0.72 | 0.91 | 0.19 | 26 | ||
2015-01-27 | 2014-12-31 | 0.78 | 0.87 | 0.09 | 11 | ||
2014-10-20 | 2014-09-30 | 0.56 | 0.77 | 0.21 | 37 | ||
2014-07-23 | 2014-06-30 | 0.5 | 0.57 | 0.07 | 14 | ||
2014-04-22 | 2014-03-31 | 0.44 | 0.53 | 0.09 | 20 | ||
2014-01-28 | 2013-12-31 | 0.44 | 0.45 | 0.01 | 2 | ||
2013-10-21 | 2013-09-30 | 0.4 | 0.45 | 0.05 | 12 | ||
2013-07-23 | 2013-06-30 | 0.39 | 0.43 | 0.04 | 10 | ||
2013-04-22 | 2013-03-31 | 0.38 | 0.46 | 0.08 | 21 | ||
2013-01-28 | 2012-12-31 | 0.41 | 0.42 | 0.01 | 2 | ||
2012-10-23 | 2012-09-30 | 0.39 | 0.41 | 0.02 | 5 | ||
2012-07-24 | 2012-06-30 | 0.37 | 0.4 | 0.03 | 8 | ||
2012-04-23 | 2012-03-31 | 0.33 | 0.36 | 0.03 | 9 | ||
2012-02-07 | 2011-12-31 | 0.31 | 0.35 | 0.04 | 12 | ||
2011-10-25 | 2011-09-30 | 0.23 | 0.22 | -0.01 | 4 | ||
2011-07-26 | 2011-06-30 | 0.37 | 0.38 | 0.01 | 2 | ||
2011-04-26 | 2011-03-31 | 0.31 | 0.35 | 0.04 | 12 | ||
2011-02-08 | 2010-12-31 | 0.29 | 0.29 | 0.0 | 0 | ||
2010-10-26 | 2010-09-30 | 0.24 | 0.3 | 0.06 | 25 | ||
2010-07-27 | 2010-06-30 | 0.23 | 0.26 | 0.03 | 13 | ||
2010-04-28 | 2010-03-31 | 0.19 | 0.21 | 0.02 | 10 | ||
2010-02-04 | 2009-12-31 | 0.2 | 0.21 | 0.01 | 5 | ||
2009-10-27 | 2009-09-30 | 0.2 | 0.17 | -0.03 | 15 | ||
2009-07-21 | 2009-06-30 | 0.18 | 0.22 | 0.04 | 22 | ||
2009-04-21 | 2009-03-31 | 0.19 | 0.2 | 0.01 | 5 | ||
2009-02-03 | 2008-12-31 | 0.17 | 0.25 | 0.08 | 47 | ||
2008-10-21 | 2008-09-30 | 0.16 | 0.15 | -0.01 | 6 | ||
2008-07-22 | 2008-06-30 | 0.14 | 0.16 | 0.02 | 14 | ||
2008-04-22 | 2008-03-31 | 0.12 | 0.13 | 0.01 | 8 | ||
2008-02-04 | 2007-12-31 | 0.12 | 0.14 | 0.02 | 16 | ||
2007-10-23 | 2007-09-30 | 0.1 | 0.13 | 0.03 | 30 | ||
2007-07-24 | 2007-06-30 | 0.06 | 0.09 | 0.03 | 50 | ||
2007-04-24 | 2007-03-31 | 0.04 | 0.06 | 0.02 | 50 | ||
2007-02-01 | 2006-12-31 | 0.15 | 0.17 | 0.02 | 13 | ||
2006-10-17 | 2006-09-30 | 0.08 | 0.16 | 0.08 | 100 | ||
2006-07-18 | 2006-06-30 | 0.01 | 0.07 | 0.06 | 600 | ||
2006-04-18 | 2006-03-31 | 0.01 | -0.0013 | -0.0113 | 113 | ||
2005-10-24 | 2005-09-30 | -0.02 | -0.01 | 0.01 | 50 | ||
2005-07-26 | 2005-06-30 | -0.03 | -0.04 | -0.01 | 33 | ||
2005-04-27 | 2005-03-31 | -0.03 | -0.01 | 0.02 | 66 | ||
2005-02-22 | 2004-12-31 | -0.02 | 0.0414 | 0.0614 | 307 | ||
2004-10-19 | 2004-09-30 | -0.04 | -0.02 | 0.02 | 50 | ||
2004-07-14 | 2004-06-30 | -0.06 | -0.05 | 0.01 | 16 | ||
2004-04-20 | 2004-03-31 | -0.08 | -0.06 | 0.02 | 25 | ||
2004-01-27 | 2003-12-31 | -0.09 | -0.06 | 0.03 | 33 | ||
2003-10-16 | 2003-09-30 | -0.11 | -0.08 | 0.03 | 27 | ||
2003-07-17 | 2003-06-30 | -0.13 | -0.13 | 0.0 | 0 | ||
2003-04-23 | 2003-03-31 | -0.12 | -0.14 | -0.02 | 16 | ||
2003-01-28 | 2002-12-31 | -0.13 | -0.12 | 0.01 | 7 | ||
2002-10-23 | 2002-09-30 | -0.14 | -0.12 | 0.02 | 14 | ||
2002-07-18 | 2002-06-30 | -0.15 | -0.14 | 0.01 | 6 | ||
2002-04-18 | 2002-03-31 | -0.14 | -0.14 | 0.0 | 0 | ||
2002-01-31 | 2001-12-31 | -0.12 | -0.13 | -0.01 | 8 | ||
2001-11-08 | 2001-09-30 | -0.1 | -0.09 | 0.01 | 10 | ||
2001-08-07 | 2001-06-30 | -0.1 | -0.1 | 0.0 | 0 | ||
2001-04-25 | 2001-03-31 | -0.09 | -0.08 | 0.01 | 11 | ||
2001-01-30 | 2000-12-31 | -0.08 | -0.08 | 0.0 | 0 | ||
2000-10-12 | 2000-09-30 | -0.1 | -0.09 | 0.01 | 10 |
Illumina Corporate Management
| Steven Hoffman | Segment Sequencing | Profile | |
| Pat Leckman | Interim Officer | Profile | |
| Ankur Dhingra | Chief Officer | Profile | |
| Nicole Berry | Head RegionAmericas | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (7.69) | Revenue Per Share | Quarterly Revenue Growth (0.02) | Return On Assets |
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.